Christopher Fowler - Concepedia

Author

Christopher Fowler

Also Known As

, Alan Rembach, Ashley I. Bush, Balebail Ashok Raj, C Fowler, C J Fowler, C J H Fowler, C. Fowler, C. J. Fowler, C. J. H. Fowler

312

Publications

9.3K

Citations

H-Index

186

Concepts

All Affiliations

The University of Melbourne Florey Institute of Neuroscience and Mental Health Austin Health Edith Cowan University Australian e-Health Research Centre

About

Christopher Fowler is an author at The University of Melbourne specializing in medicine, neurology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	283
2	Engineering	4	4	53
3	Education	2	2	518
4	Business	1	1	17
5	Language Studies	1	1	435

Christopher Fowler

110

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
High performance plasma amyloid-β biomarkers for Alzheimer’s disease Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne, Nature Neurodegenerative DiseasesAlzheimer's DiseaseBiomarkersNeurochemical BiomarkersProtein Misfolding	2018	1.6K
Virtual reality and learning: Where is the pedagogy? Christopher Fowler British Journal of Educational Technology Educational EnvironmentsE-learningVirtual EnvironmentsEducationDigital Learning Environment	2014	435
Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment Lesley Cheng, James D. Doecke, Robyn A. Sharples, Molecular Psychiatry Neuroimaging BiomarkersNeurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseBiomarkers	2014	401
Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease Xavier Hadoux, Flora Hui, Jeremiah K. H. Lim, Nature Communications	2019	278
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort Pratishtha Chatterjee, Steve Pedrini, James D. Doecke, Alzheimer s & Dementia	2022	260
High performance plasma amyloid-beta biomarkers for Alzheimer's disease Akinori Nakamura, Naoki Kaneko, Victor L. Villemagne, Nature Alzheimer's DiseaseDementiaNeurophysiological BiomarkersBiomarkersNeurochemical Biomarkers	2018	204
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals Noelia Fandos, Virginia Pérez‐Grijalba, Pedro Pesini, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2017	180
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques Yan Li, Suzanne E. Schindler, James G. Bollinger, Neurology	2021	178
Total Aβ <sub>42</sub> /Aβ <sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis James D. Doecke, Virginia Pérez‐Grijalba, Noelia Fandos, Neurology	2020	173
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease Christopher Fowler, Stephanie R. Rainey‐Smith, Sabine Bird, Journal of Alzheimer s Disease Reports	2021	162

Page 1